PTN


Roth Capital Pounds The Table On Palatin Technologies, Inc. (PTN)

Roth Capital analyst Michael Higgins was out pounding the table on shares of Palatin Technologies, Inc. (NYSEMKT:PTN) Tuesday, resuming coverage with a Buy rating and a …

Monday’s Healthcare News: AMAG Pharmaceuticals, Inc. (AMAG), Galena Biopharma Inc (GALE), Ariad Pharmaceuticals, Inc. (ARIA)

Today’s healthcare sector offered a great deal of rumble and tumble with the following volatile stocks making headlines today: AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), …

Stock Update (NYSEMKT:PTN): Here’s Why Palatin Technologies, Inc. Shares Took a Hit Today

Palatin Technologies, Inc. (NYSEMKT:PTN) announced today that it intends to offer and sell, subject to market and other conditions, 25,384,616 shares of its …

Roth Capital Confident on Palatin Technologies, Inc. (PTN) Following F1Q17 Results

Yesterday, Palatin Technologies, Inc. (NYSEMKT:PTN) announced its fiscal first quarter results for 2017, with Roth Capital analyst Joseph Pantginis determining that “all eyes” …

Canaccord Bullish on Palatin Technologies, Inc. (PTN) Ahead of SSE Data and Partnership Update

Canaccord analyst John Newman speculates on Palatin Technologies, Inc. (NYSEMKT:PTN) ahead of clinical data and partnership updates with a bullish forecast, reiterating a …

Roth Capital Cheers Palatin Technologies, Inc. (PTN) Clinical Success; Boosts Price Target

Palatin Technologies, Inc. (NYSEMKT:PTN) shares were on a close to 18% rise after market close yesterday after the firm’s pipeline drug bremelanotide (BMT), …

Palatin Technologies, Inc. (PTN): Partnership Discussions Likely to Accelerate, Says Canaccord

Palatin Technologies, Inc. (NYSEMKT:PTN) shares jumped 18% today after the company’s key pipeline drug bremelanotide, designed to treat female sexual dysfunction (FSD), hit …

Analysts Weigh in on Three Rising Healthcare Stocks: Palatin Technologies, Inc. (PTN), Novocure Ltd (NVCR) and AveXis Inc (AVXS)

Healthcare stocks Palatin Technologies (NYSEMKT:PTN), Novocure Ltd (NASDAQ:NVCR), and AveXis Inc (NASDAQ:AVXS) are reaping the benefits of clinical and corporate progress updates that have sent the …

Canaccord Bullish on Palatin Technologies, Inc. (PTN) Ahead of Top-Line Phase 3 Data

In a research report released Tuesday, Canaccord analyst John Newman reiterated a Buy rating on shares of Palatin Technologies, Inc. (NYSEMKT:PTN) with a $6.

Analysts Weigh In on Two Healthcare Stocks: Gilead Sciences, Inc. (GILD), Palatin Technologies, Inc. (PTN)

Analysts are weighing in on the biotechnology giant Gilead Sciences, Inc. (NASDAQ:GILD) and pharmaceutical company Palatin Technologies, Inc.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts